Home326030 • KRX
add
SK Biopharmaceuticals Co Ltd
Previous close
₩89,600.00
Day range
₩88,500.00 - ₩90,100.00
Year range
₩70,900.00 - ₩104,800.00
Market cap
7.02T KRW
Avg Volume
85.36K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 126.76B | 101.95% |
Operating expense | 98.00B | 1.21% |
Net income | 6.76B | 115.41% |
Net profit margin | 5.33 | 107.63% |
Earnings per share | — | — |
EBITDA | 19.27B | 146.75% |
Effective tax rate | -148.91% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 241.12B | -21.06% |
Total assets | 723.17B | 8.87% |
Total liabilities | 402.22B | 15.69% |
Total equity | 320.95B | — |
Shares outstanding | 78.31M | — |
Price to book | 24.73 | — |
Return on assets | 5.01% | — |
Return on capital | 7.37% | — |
Cash Flow
Net change in cash
(KRW) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 6.76B | 115.41% |
Cash from operations | -18.31B | 58.40% |
Cash from investing | -2.42B | -104.64% |
Cash from financing | -9.88B | -343.46% |
Net change in cash | -31.69B | -178.34% |
Free cash flow | -22.19B | 54.43% |
About
Founded
1993
Website